with a delay in its other code 1000 baxi candidate for which it has partnered with britain's glaxo smith kline the european commission to order it up to 300000000 vaccine doses off the sanofi g s k vaccine for the 27 member states. well for more let's cross over now to our financial market correspondent to chelsea delaney in frankfurt chelsea the 2nd time sanofi failed in its attempt to produce an effective covert $960.00 what's that mean for the french pharma company . it's a major just appointment for. the company had invested a lot of money and a lot of time into building out these vaccine programs and both of them just aren't really bearing fruit at this moment so that's a lot of wasted time that's a lot of wasted money and senator he also had been really the front runner at the beginning of the vaccine race they had received a lot of investment from different governments that was really seen as one of the most promising candidates and now both candidates are really following through but i'd say this is also a bit of a blow to france in general you know the whole. story of the founder of v

with a delay in its other covert 1000 vaccine candidate for which it partnered with britain's glaxo smith kline the e.u. commission has ordered up to 300000000 doses of the sanofi t.s.k. vaccine for the 27 member states earlier we asked our correspondent in frankfurt chelsea delaney what this means for a son off the the e use vaccine role. at the beginning of the coronavirus vaccine race sanity was seen as having one of the most promising candidates there really been a global fight to secure 1st access to the doses that sanity was producing definitely a major blow for the company that both of its vaccine can't bets aren't going to be ready by the end of the year it's also a problem for the e.u. which has really got big on sand if you stack scene say it ordered about 300000000 doses of the vaccine it was developing with glaxo smith kline for now that you are saying they're not too worried about that that they'll be able to make up for that shortfall by raising production and getting more vaccines from other vaccine manufacturers like pfizer and biotech and astra zeneca and sort of you for its pa

if you stack scene say it ordered about 300000000 doses of the vaccine it was developing with glaxo smith klineso now that you are saying they're not too worried about that that they'll be able to make up for that shortfall by raising production and getting more vaccines from other vaccine manufacturers like pfizer and biotech and astra zeneca and so have you for its part is saying that it wants to help out it's offered up its production facilities and is helping for example pfizer and biotech here in frankfurt produce about 125000000 doses by the end of the year. today is holes in one talk or rose monday the climax of germany's carnival season normally there be millions of carnival ruffler is especially in the rhineland area i was on the streets singing and dancing but this year none of that is taking place this year carnival has been cancelled due to the pandemic a move that will cost the german economy $1500000000.00 euros according to the german economic institute in cologne retailers hotels on the transport sector it will all be missing irish it's a similar picture across the world the fam

with laxer smith kline that leaves the big hole and its its plans for a rollout now and we've already seen in europe really struggling to get enough vaccines but we also have seen center and glaxo smith kline say that they will start manufacturing other companies krone virus vaccines they play i said a few plans to manufacture about 125000000 doses of the pfizer biotech vaccine so hopefully that will help to fill some of these production shortfalls as a result of the delays in santa fees vaccines chalcedony they're reporting for us from the frankfurt stock exchange thank you so much. today is was more talk or shroff monday a climax of germany's carnival season and normally that be millions of carnival revolution especially in the rhineland out on the streets singing and dancing but not this year lots during the coronavirus pandemic this year accountable has been cancelled and that is costing the german economy a whopping one and a half 1000000000 euros according to the german economic institute in cologne retailers hotels on transport sickness all missing out and it's a similar picture across the world to the famous venice carnival this year is going on line with digital partie

with a delay in its other covert 19 vaccine condors that for which it partnered with britain's glaxo smith kline the e.u. commission has ordered up to 300000000 doses of this one of the g s k vaccine for the 27 member states earlier we asked our correspondent in frankfurt chelsea delaney what this means for some of the e.u. vaccine roll. at the beginning of the coronavirus vaccine race tennessee was seen as having one of the most promising candidates there really been a global fight to secure 1st access to the doses that santa fe was producing definitely a major blow for the company that both of its vaccine can't bets aren't going to be ready by the end of the year it's also a problem for the u. which has really got big on sand if you stack scene say ordered about 300000000 doses of the vaccine it was developing with glaxo smith kline for now that you are saying they're not too worried about that that they'll be able to make up for that shortfall by raising production and getting more vaccines from other vaccine manufacturers like pfizer and biotech and astra zeneca and set up here for its part

manufacturers astra zeneca is the biggest shareholder in madonna with a 7.7 percent stake and glaxo smith kline which had a troubled attempt with its partner to develop a coded 1000 vaccine has bought a 10 percent stake in german biotech cure back. this is where the technology gets really exciting you see it offers the potential to create drugs and vaccines for cancer which kills in 1000000 people worldwide well joining me now from about the capital city of morocco is dr as it in a pariah me as the is the director of med biotech the medical biotechnology lab and head of the biotechnology lab at the robot medical school good to have you with us so in technological terms just how important is to science and humanity or actually thank you for having me to talk about this technology but it's a great a think an amended maze that we could do it actually this is the reason we thought it would be a dream for many years but no i think we are getting closer and closer to having this technology applied and actually been able to produce proteins and cure a lot of the diseases that we couldn't actually thin

really got big on santa fe ordered about 300000000 doses of the vaccine it was developing with glaxo smith kline for now that you are saying they're not too worried about that that they'll be. well to make up for that shortfall by raising production and getting more vaccines from other vaccine manufacturers like pfizer and biotech and astra zeneca and set up here for its part is saying that it wants to help out it's offered up its production facilities and is helping for example pfizer and biotech here in frankfurt produce about 125000000 doses by the end of the year chelsea delaney and frankfurt there let's head to cameroon now for traders are making huge profits out of selling fuel illegally smugglers sell the stolen petrol at significantly lower prices than a conventional service stations do to our reporter blasé young spoke to illegal vendors and their customers in the city of moore in northern cameron official protest issues like these are losing business to illegal for traders income rude still in full force is rigidly available for treat in the country for 7 years. has been selling illega

but veer biotechnology shares are jumping after they announced the covid-19 partnership with glaxo smith klines glasso also increasing next hour by the way, company ceo will join "squawk alley" to discuss that announcenemt. and a lot more you will not want to miss that one what we have coming up here on "squawk on the street" right after this folks the world's first fully autonomous vehicle is almost at the finish line today we're going to fine tune the dynamic braking system whoo, what a ride! i invested in invesco qqq a fund that invests in the innovators of the nasdaq 100 like you you don't have to be a deep learning engineer to help make the world a smarter place does this come in blue? become an agent of innovation with invesco qqq woo! you are busy... working, parenting, problem solving. does this come in blue? at new chapter vitamins we've been busy too... innovating, sourcing organic ingredients, testing them and fermenting. fermenting? yeah like kombucha or yogurt. and we formulate everything so your body can really truly absorb the natural goodness. that's what we do, so you can do y